For press inquiries click here to contact us.
Xaira Therapeutics
Secretive Biotech Xaira Hires Top AI Academic To Take His Work to ‘the Next Level’
Eikon Therapeutics
Eikon Therapeutics Raises $350.7M in Series D Funding
Alumis, Inc.
Alumis and Kaken Pharma ink deal for ESK-001 in dermatology in Japan
Alumis, Inc.
ESK-001: A Conversation with Jörn Drappa, MD, PhD, of Alumis on Breakthrough Data and the Future of Psoriasis Treatment
Alumis, Inc.
AAD25: Ahead of Acelyrin merger, Alumis flexes mid-stage data for oral TYK2 inhibitor in psoriasis
Genomics PLC
Bupa to offer first genetic test for disease prediction in UK
Avenzo Therapeutics
Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio
Element Biosciences
Element Biosciences AVITI Sequencing
Xaira Therapeutics
Eye On AI: Funding To Biotech And Healthcare Startups Using AI Takes Off After Dip In 2023
Please see important disclaimers in the Terms section.
